Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03858855 · ClinicalTrials.gov registry record · NA
Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment
A NA study, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 248
- Enrollment target
NCT03858855 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 248 participants.
The verdict
NCT03858855, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
Study Summary
This single-blind, randomized controlled trial studies how well inhaled essential oils work for common quality of life concerns in patients who are undergoing cancer treatment such as chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously). Aromatherapy using essential oils, such as ginger essential oil, German chamomile essential oil, and bergamot essential oil, may improve quality of life issues such as nausea, anxiety, loss of appetite, and fatigue in patients undergoing treatment for cancer.
Interventions
- PROCEDURE Aromatherapy and Essential Oils
- OTHER Subject Diary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2020-04-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03858855
The ClinicalTrials.gov registry entry for NCT03858855 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 248 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Aromatherapy and Essential Oils is the first listed.
NCT03858855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03858855 about?
NCT03858855 is a clinical study titled "Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment". This single-blind, randomized controlled trial studies how well inhaled essential oils work for common quality of life concerns in patients who are undergoing cancer treatment such as chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously). Aromatherapy using esse...
What is the current status of trial NCT03858855?
This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2019-02-18. Estimated completion is 2020-04-13.
What interventions are being tested in trial NCT03858855?
The interventions under investigation include: Aromatherapy and Essential Oils (PROCEDURE), Subject Diary (OTHER).
Who is sponsoring clinical trial NCT03858855?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.